Probiodrug to Present an Update on QC Inhibition as Potential New Treatment for Alzheimer’s Disease at the Society for Neuroscience Meeting 2008, Nov. 15-19, 2008, Washington, DC

Nature Medicine Publication Elucidating Probiodrug´s New Treatment Paradigm for Alzheimer’s disease
US PTO granting Probiodrug a Further Medical Use Patent for the Inhibition of the Enzyme Glutaminyl Cyclase (QC)